COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 166: Articles 1651-1660  | Next

Publication trend, impact and performance in mental health during and post COVID-19 pandemic
Bahar, N., Nor Rashid, F. A., Ahmad, N. D.
10.1101/2024.07.04.24309983 — Posted: 2024-07-07
From a single sequence to evolutionary trajectories: protein language models capture the evolutionary potential of SARS-CoV-2 protein sequences
Lamb, K. D., Hughes, J., Lytras, S., Koci, O., Young, F., Grove, J., Yuan, K., Robertson, D. L.
10.1101/2024.07.05.602129 — Posted: 2024-07-06
Relationship between acute SARS-CoV-2 viral clearance with Long COVID Symptoms: a cohort study
Herbert, C. B., Antar, A. A., Broach, J., Wright, C., Stamegna, P., Luzuriaga, K., Hafer, N., McManus, D. D., Manabe, Y. C., Soni, A.
10.1101/2024.07.04.24309953 — Posted: 2024-07-05
Improved estimates of COVID-19 correlates of protection, antibody decay and vaccine efficacy waning: a joint modelling approach
Phillips, D. J., Christodoulou, M. D., Feng, S., Pollard, A. J., Voysey, M., Steinsaltz, D.
10.1101/2024.07.02.24309776 — Posted: 2024-07-05
Long COVID Brain Fog Treatment: Findings from a Pilot Randomized Controlled Trial of Constraint-Induced Cognitive Therapy
Uswatte, G., Taub, E., Ball, K., Mitchell, B. S., Blake, J. A., McKay, S., Biney, F., Iosipchuk, O., Hempfling, P., Harris, E., Dickerson, A., Lokken, K., Knight, A. J., Mark, V. W., Cutter, G.
10.1101/2024.07.04.24309908 — Posted: 2024-07-05
Short-Term Relative Effectiveness of Homologous NVX-CoV2373 and BNT162b2 COVID-19 Vaccinations in South Korea
Gwak, E., Choe, S.-A., Bolormaa, E., Choe, Y. J., Wang, C., Fix, J., Vadivale, M., Rousculp, M. D.
10.1101/2024.07.02.24309830 — Posted: 2024-07-05
Early and accurate prediction of COVID-19 hospitalization risk and symptomatic course of SARS-CoV-2 infection
Holetschek, C., Goekkaya, M., Dorgham, K., Eder, P., Luschkova, D., Parizot, C., Tekinsoy, M., Rauer, D., Samri, A., Early-Opt-COVID19 Study Group, , Reiger, M., Hammel, G., Steininger, P., Gilles, S., Protzer, U., Roemmele, C., Gorochov, G., Traidl-Hoffmann, C., Neumann, A. U.
10.1101/2024.07.05.24309641 — Posted: 2024-07-05
Evaluating the COVID-19 responses of Belgium, Denmark, Germany, the Netherlands, Sweden and the United Kingdom, February-June 2020: A counterfactual modelling study
de Boer, P. T., Miura, F., Lagerweij, G. R., Wallinga, J.
10.1101/2024.07.05.24309992 — Posted: 2024-07-05
Developing a bioinformatics pipeline to detect Delta and Omicron co-infection cases in the Philippines during SARS-CoV-2 genomic surveillance
Realingo, A. M. L., Polotan, F. G. M., Abulencia, M. F. B., Pantoni, R. A. R., Capin, J. B. G., Sotelo, G. I., Corpuz, M. C. A., Yabut, N. T. M., Rojas, S. M., Nicolasora, A. D., Tujan, M. A., Tomas, K. I., Dolor, A. Y., Celis, C. C. A., Ortia, S. P., Melo, E., Reyes, C. M., Flores, E. M. P., Alpino, A. P. A., Penales, A. K. A., Medina, K. M. C., Manalo, J. I., Dancel, L. L., Dizon, T. J. R., Kasaragod, S., Hampson, K., Hughes, J., Brunker, K.
10.1101/2024.07.03.24309627 — Posted: 2024-07-05
Type 1 diabetes risk and severity after SARS-CoV-2 infection or vaccination
Stene, L. C., Lopez-Doriga Ruiz, P., Ljung, R., Boas, H., Gulseth, H. L., Pihlstrom, N., Sundstrom, A., Zethelius, B., Stordal, K., Gani, O., Lund-Blix, N. A., Skrivarhaug, T., Tapia, G.
10.1101/2024.07.03.24309894 — Posted: 2024-07-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).